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Robo4 is an endothelial cell-specific member of the
Roundabout axon guidance receptor family. To iden-
tify Robo4 binding partners, we performed a protein-
protein interaction screen with the Robo4 extracel-
lular domain. We find that Robo4 specifically binds
to UNC5B, a vascular Netrin receptor, revealing
unexpected interactions between two endothelial
guidance receptors. We show that Robo4 maintains
vessel integrity by activating UNC5B, which inhibits
signaling downstream of vascular endothelial growth
factor (VEGF). Function-blocking monoclonal anti-
bodies against Robo4 and UNC5B increase angio-
genesis and disrupt vessel integrity. Soluble Robo4
protein inhibits VEGF-induced vessel permeability
and rescues barrier defects in Robo4/ mice, but
not in mice treated with anti-UNC5B. Thus, Robo4-
UNC5B signaling maintains vascular integrity by
counteracting VEGF signaling in endothelial cells,
identifying a novel function of guidance receptor
interactions in the vasculature.
INTRODUCTION
The vascular system is a highly branched network of arteries,
capillaries, and veins that supplies all body tissues with oxygen
and nutrients and removes waste. Endothelial cells (EC) that
line mature blood vessels form a barrier that prevents leakage
of protein and fluid into tissues. Formation of new blood vessels
requires release of angiogenic growth factors such as VEGF,
which disrupts the EC barrier and induces vascular leak and
sprouting of new vessel branches (Adams and Alitalo, 2007;
Gavard and Gutkind, 2006). Activation of quiescent EC by
VEGF is mediated by binding to its high affinity receptor VEGFR2Deveand receptor autophosphorylation, which leads to activation of
intracellular signaling cascades that execute VEGF signaling,
including Src family kinases (Eliceiri et al., 1999; Gavard and
Gutkind, 2006). Appropriate regulation of the VEGF response is
required to ensure vessel stability, patterning of neovessels
and proper tissue blood supply.
Recent studies have suggested that Robo4 inhibits VEGF
downstream signaling (Jones et al., 2008, 2009; London et al.,
2010; Marlow et al., 2010). Robo4 belongs to a family of four
Roundabout receptors identified in vertebrates. Robo1-3 are
single-pass transmembrane receptors for repulsive axon guid-
ance molecules of the Slit family. Robo1-3 participate in the
guidance of commissural axons by preventing axons that have
crossed themidline from re-crossing (Brose et al., 1999; Dickson
and Gilestro, 2006; Kidd et al., 1998; Long et al., 2004; Stein and
Tessier-Lavigne, 2001). In contrast to the other Robo receptors,
which are mainly expressed in the nervous system, Robo4
expression is selective for vascular EC, including the tumor
vasculature (Huminiecki et al., 2002; Okada et al., 2007).
Robo4/ mice are viable, but exhibit increased basal and
VEGF-induced retinal vascular permeability and show hypervas-
cularization during experimentally induced pathological ocular
neovascularization (Jones et al., 2008). These data suggest
that Robo4 is required tomaintain blood vessel integrity by coun-
teracting VEGF and acts as a negative regulator of angiogenesis
in these model systems.
Compared to the other Robo receptors, Robo4 is not only
expressed in a different tissue environment (i.e., the vascular
system as opposed to the nervous system), but is also structur-
ally divergent and contains only two IgG-like domains and two
FNIII repeats in the extracellular domain (ECD) and lacks the
CC1 and CC3 motifs found in the intracellular domain of most
other Robo proteins (Fukuhara et al., 2008; Hussain et al.,
2006; Morlot et al., 2007). As the ECD is structurally divergent,
it remains currently unclear if Robo4 can bind to Slit proteins.
Binding of Slit-2 to Robo4 has been shown using supernatant
from myc-tagged Slit-2 transfected cells added to Robo4lopmental Cell 20, 33–46, January 18, 2011 ª2011 Elsevier Inc. 33
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et al., 2009), whereas Slit binding to Robo4 has not been
observed in Biacore binding assays (Suchting et al., 2005).
As Robo4 function seems critical for proper vascular patterning,
we set out to identify molecules binding to the Robo4 extracel-
lular domain. Using a protein-protein interaction screen with
a Robo4 extracellular domain (ECD)-Fc fusion protein as a bait,
we identified a single interaction partner, which surprisingly
turned out to be another vascular-specific axon guidance
receptor, UNC5B (Leonardo et al., 1997; Lu et al., 2004). Our
data show that Robo4 acts as a membrane-bound UNC5B
ligand and support a model where UNC5B acts as a signaling
receptor that is required to maintain vessel integrity and barrier
function by blocking VEGF-mediated downstream signaling.RESULTS
Robo4 Binds UNC5B with High Affinity
To identify putative Robo4 ligands, we used Robo4-ECD-Fc
protein to screen 1900 secreted proteins and ECD protein
constructs of a secreted protein library (Clark et al., 2003) by
biolayer interferometry. This protein-protein interaction screen
revealed a highly selective interaction between Robo4 and the
ECD of UNC5B, a vascular-specific Netrin receptor (Leonardo
et al., 1997; Lu et al., 2004) (see Figures S1A and S1B available
online). Surface plasmon resonance (SPR) direct binding experi-
ments confirmed specific, dose-dependent binding of Robo4-Fc
to UNC5B-Fc but not to a number of unrelated control proteins
(Figure 1A). Fc- and His-tagged versions of the Robo4 ECD con-
taining only the first two immunoglobulin-like (Ig-like) domains
were sufficient to bind UNC5B, localizing the binding site within
these domains; a KD of 12 nM was measured for this interaction
(Figures 1B and 1C), which is in the same range as the binding
of Netrin-1 to UNC5B (3.4 nM) (Leonardo et al., 1997).
Toconfirm theSPR results in a cell-basedassay,weexpressed
full-length Robo4, UNC5B, and Netrin-1 constructs in COS cells
and incubated them with alkaline-phosphatase (AP)-tagged
UNC5B and Robo4 ECD proteins (Figure 1D). UNC5B AP bound
to Netrin-1 and Robo4, but not to Netrin-4 (data not shown) or to
itself, whereas Robo4 AP only bound to UNC5B expressing cells
(Figure 1D). UNC5BAPstainingwas restricted to cells expressing
Robo4 and vice versa as demonstrated by immunofluorescence
of cells transiently transfected with Robo4 GFP- or UNC5B
Cherry-tagged receptor constructs (Figure S1C).
As Robo4 had previously been reported to bind to Slit-2, we
also tested binding of the Robo4 and Robo1 ECD to Slit-2.Figure 1. Robo4 Binds UNC5B
(A–C) SPR binding measurements confirm that Robo4-Fc binds specifically to U
Robo4-Fc and six unrelated control proteins were injected at different concentrati
including Robo4-Ig2-Fc bind to immobilized UNC5B-Fc but UNC5B does not bin
immobilized onto a GLC chip (ProteOn, BioRad) and binding sensorgrams for
simultaneously. The equilibrium dissociation constant (KD) was calculated from
and dissociation sensorgrams.
(D) COS cells transfected as indicated or untransfected (control) were seeded on
tative images from one of three independent experiments are shown. UNC5B-A
Slit-2.
(E) AP-fusion protein binding to cryo sections from E11.5 hindbrains ofUnc5b+/+ o
Dotted line: midline. Red arrows: perineural vascular plexus. Black arrows: intrac
DeveRobo4-AP did not bind to cells expressing Slit-2, whereas
a Robo1-ECD-AP fusion protein did (Figure 1D). Likewise,
Slit-2-AP bound to cells expressing Robo1, but not to cells ex-
pressing Robo4 (Figure S1D). Recombinant purified Robo1
ECD efficiently bound Slit-2 in SPR binding experiments,
whereas the Robo4 ECD failed to show Slit-2 binding (Fig-
ure S1E). Finally, Slit-2-AP binding was similar on tissues of
wild-type and Robo4/ mice (Figure S1F), demonstrating that
Robo4 is not required for Slit-2 binding in vivo.
To determine if Robo4 binds to UNC5B in vivo, we incubated
sections of E11.5 mouse embryos with AP-tagged Robo4 and
VEGFproteins. VEGF-AP labeled EC expressing VEGF receptors
in sections of both wild-type and Unc5b/ embryos. Robo4-AP
stainedEC in thehindbrain andperineural vascular plexus inwild-
type embryos expressingUNC5B, but noRobo4-AP stainingwas
observedonsectionsofUnc5b/embryos (Figure 1E); in factwe
could not detect staining in any part of the Unc5b/ embryos
(data not shown), demonstrating that UNC5B expression is
required for Robo4 binding in vivo. These data show that
UNC5B is a high-affinity binding partner for Robo4.
We used SPR binding assays to test if Robo4 and Netrin-1
bind to the same, or to distinct domains of the UNC5B ECD. Ne-
trin-1 and Robo4 bind noncompetitively to an UNC5B construct
that comprises the entire UNC5B ECD (Figure S1G). Netrin-1,
but not Robo4 binds to a construct encoding only the N-terminal
Ig-like domains, indicating that Robo4 and Netrin-1 bind to
distinct UNC5B domains (Figures S1G and S1H).Robo4 Acts as an UNC5B Ligand
Both Robo4 and UNC5B are transmembrane receptors with
a cytoplasmic domain that could mediate signaling (Huminiecki
et al., 2002; Leonardo et al., 1997). In addition, both receptor
proteins are coexpressed in EC, as shown by whole-mount im-
munostaining of dermal capillaries and diaphragm (Figure 2A;
Figure S2A). These observations raise several possible
scenarios for Robo4-UNC5B interactions UNC5B and Robo4
could act as coreceptors and signal in cis, or, alternatively,
they could signal in trans between neighboring endothelial cells,
either uni- or bidirectionally.
To test if UNC5B can activate Robo4 signaling, we used
porcine aortic EC (PAECs) expressing GFP-tagged full-length
Robo4. Incubation of these cells with UNC5B-Fc did not stimu-
late Robo4 internalization (Figure 2B). However, we observed
only low Robo4 levels at the PAEC surface, whereas most
receptor localized to intracellular vesicles (data not shown).
Cytoplasmic Robo4 localization was not affected byNC5B. (A) UNC5B-Fc was immobilized onto a Biacore CM5 sensor chip and
ons for 120 s and allowed to dissociate for 240 s. (B) Different Robo4 constructs
d to itself (no homo association). (C) For affinity measurements UNC5B-Fc was
six different Robo4-Ig2-His concentrations (6.25 to 200 nM) were recorded
the on- and off-rates obtained by simultaneous fitting of the association
triplicate wells and incubated with the indicated AP-fusion proteins. Represen-
P binds Netrin-1 and Robo4, Robo4-AP binds UNC5B, and Robo1-AP binds
r / embryos as indicated. Note absence of Robo4AP binding toUnc5b/ EC.
erebral capillaries. Scale bars represent 50 mm (see also Figure S1).
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tion with UNC5B in trans (data not shown). Radioligand cell
binding experiments with a specific anti-Robo4 antibody (see
below) revealed low cell surface copy numbers for endogenous
Robo4 onmurine (MS1) and human (HUVEC) ECs confirming the
low Robo4 surface expression (Figures S2B and S2C). These
results precluded further examination of possible Robo4
signaling effects after stimulation with UNC5B.
In contrast, stimulation of PAECs transfected with a GFP-
tagged UNC5B-full-length construct (UNC5B-Fl) with Robo4-
Ig2-His protein (hereafter termed sRobo4) or Netrin-1 led to
UNC5B internalization and decrease of surface GFP fluores-
cence (Figure 2C; Figure S2D). To test activity of full-length
Robo4, we cocultured UNC5B cells and 293 cells transfected
with a Cherry-tagged Robo4-Fl construct. Video-microscopy
showed that as soon as a Robo4 expressing cells touched an
UNC5B-Fl expressing cells, GFP-tagged UNC5b receptors
aggregated and the cells retracted from the Robo4 expressing
cells (data not shown). Repulsion was quantified after 24 hr of
coculture, by measuring the overlap between red 293 cells and
green UNC5B PAECs. In control cocultures between untrans-
fected red labeled 293 cells and UNC5B-Fl PAECs, cells mix,
leading to overlap of red cells by green cells, with 80% of the
surface area of the control 293 cells covered by PAECs (Fig-
ure 2D). Repulsion of UNC5B cells by Robo4-Fl cells leads to
segregation of the two populations, i.e., significant reduction in
overlap of red and green cells compared to controls (Figure 2D).
Expression of a truncated Robo4 receptor lacking the cyto-
plasmic signaling domain (Robo4DCD) in 293 cells was sufficient
to repel UNC5B-expressing PAECs (Figure 2D). Coculture with
293 cells expressing Netrin-1 likewise induces UNC5B repulsion
and segregation (Larrivee et al., 2007) (Figure 2D).
Expression of a truncated UNC5B receptor lacking the
cytoplasmic signaling domain (UNC5BDCD) in PAECs abolished
retraction in response to 293 cells expressing Robo4-Fl,
Robo4DCD, and Netrin-1, indicating that UNC5B signaling is
required for repulsion to occur (Figure 2E). Robo4 therefore acts
as a repulsive transmembrane ligand for UNC5B when presented
in trans, similar to the established secreted ligand Netrin-1.
To examine if Robo4 triggered signaling events in EC express-
ing endogenous UNC5B, serum-starved human umbilical arteryFigure 2. Robo4 Acts as an UNC5B Ligand
(A) Confocal images of dermal capillaries from 6-week-old wild-type mice labeled
Robo4 and UNC5B in EC.
(B) PAECs expressing GFP-tagged Robo4 were incubated with UNC5B-Fc and a
cells are shown. Note no change in surface fluorescence after treatment.
(C) PAECs expressing GFP-tagged UNC5B were incubated with Netrin-1 and
fluorescence after ligand treatment.
(D) Robo4 repels UNC5B expressing cells when presented in trans. UNC5B-Fl e
transfected 293 cells as indicated. Cell mixing in control cocultures leads to over
independent experiments. Expression of Robo4-Fl, Robo4DCD, or Netrin-1 in 293
red cells by green cells.
(E) Expression of UNC5BDCD in PAECs abolishes repulsion.
(F) HUAECs were serum starved (control) and stimulated with Netrin-1 or sRob
polyacrylamide gel electrophoresis and western blots were incubated with the ind
ylation.
(G) PAECs expressing UNC5Bwere serum starved (control) and stimulated with lig
an anti-UNC5B antibody (R&D). Both UNC5B ligands enhance UNC5B associati
(H) Robo4 activates UNC5B signaling. Scale bars: 15 mm (A), 30 mm (D and E). E
(Student’s t test) (see also Figure S2).
DeveEC (HUAECs) were incubated with Netrin-1 and sRobo4. Both
ligands increased phosphorylation levels of ERK and Src, but
did not stimulate AKT phosphorylation (Figure 2F). Stimulation
of EC isolated from Unc5b/ mice with sRobo4 failed to
increase Src phosphorylation, indicating that UNC5B is required
for Src activation in response to sRobo4 (Figure S2E). Immuno-
precipitation with an anti-Src antibody and western blotting with
anti-UNC5B showed that UNC5B coimmunoprecipitated with
Src after stimulation with Netrin-1 or sRobo4 (Figure 2G). To
test if blocking Src phosphorylation inhibited UNC5B signaling
and biological response, we cocultured Robo4 expressing 293
cells with UNC5B expressing PAECs in the presence or absence
of the Src family kinase inhibitor PP2 (Hanke et al., 1996). PP2
treatment efficiently blocked Src phosphorylation in PAECs
and did not alter PAEC morphology or cell division (data not
shown). However, PP2 completely blocked segregation of
UNC5B expressing PAECs from Robo4 expressing 293 cells
(Figure S2F). These results support a model in which Src activa-
tion and association with UNC5B is required for signal transduc-
tion and response to Robo4 (Figure 2H).
Generation of Antibodies Blocking Robo4 and UNC5B
To explore biological effects of Robo4-UNC5B interactions, we
generated high-affinity, phage-derived monoclonal antibodies
(mAbs) against the N-terminal Robo4 IgG like domains (Fig-
ure 3A). Among several candidates, we identified one antibody,
anti-Robo4-1, that efficiently blocked binding of Robo4 to
UNC5B-Fc in SPR binding assays, whereas two other anti-
bodies, anti-Robo4-2 and anti-Robo4-3 only partially blocked
UNC5B binding (Figure 3B). Based on these SPR data, anti-
Robo4-1 was used in all subsequent experiments. Anti-Robo4-
1 is an affinity matured, phage-derived human IgG1 mAb that
binds with a KD of 1 nM to human and murine Robo4 in SPR
and in cell binding (HUVECs, MS1) experiments (N.R., unpub-
lished data). Treatment of UNC5B-GFP PAECs with anti-
Robo4-1 blocked sRobo4-induced UNC5B internalization (Fig-
ure 3C). In cocultures between UNC5B-GFP PAECs and
Robo4-Cherry-expressing 293 cells, anti-Robo4-1 blocked
Robo4- induced cell segregation (Figure S3A). These data
show that anti-Robo4-1 efficiently blocks Robo4-UNC5B inter-
actions in solution and in cells.with anti-UNC5B (R&D), anti-Robo-4-1 and IsolectinB4. Note coexpression of
nalyzed by FACS. Histograms of fluorescence intensity compared to untreated
Robo4-Ig2-His (sRobo4) and analyzed by FACS. Note decrease in surface
xpressing PAECs were cocultured with red-labeled untransfected (control) or
lap of red cells by green cells, which was measured on 10 images/well in three
cells induces repulsion of UNC5B cells, which leads to a reduction in overlap of
o4 as indicated. Protein extracts were subjected to sodium dodecyl sulfate
icated antibodies. Both Netrin-1 and sRobo4 stimulate Src and ERK phosphor-
ands for 30min, followed by Src immunoprecipitation andwestern blottingwith
on with Src.
rror bars represent standard error of the mean (SEM). **p < 0.01, ***p < 0.001
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Figure 3. Generation of Function Blocking Anti-Robo4 and Anti-UNC5B Antibodies
(A) Schematic diagram of Robo4. Phage derived antibodies were raised against the two N-terminal Ig domains of Robo4.
(B) Anti-Robo4-1 blocks Robo4 binding to UNC5B. For SPR binding and binding/competition experiments UNC5B-Fc was immobilized onto a ProteOn GLC
sensor chip and sRobo4 or equimolar mixtures of sRobo4 with anti-Robo4 antibodies were injected and allowed to bind for 240 s. Note that the decrease of
the binding signal for the Robo4/anti-Robo4-2 and -3 complexes indicates that these antibodies interfere with the Robo4-UNC5B interactions whereas
a complete loss of binding for the Robo4/anti-Robo4-1 complex shows that Robo4-1 completely blocks the interaction.
(C) Pretreatment of UNC5B-GFP expressing PAECs with anti-Robo4-1 (50 mg/ml) blocks sRobo4 induced UNC5B internalization.
(D) Schematic diagram of UNC5B. Phage derived antibodies were raised against the two N-terminal Ig domains of UNC5B.
(E) Binding affinities for anti-UNC5B antibodies to human and murine UNC5B as determined by SPR measurements.
(F) UNC5B-GFP expressing PAECs were cultured in the presence of 100 mg/ml anti-UNC5B-1 or anti-UNC5B-2 for 12 hr. FACS analysis shows that anti-UNC5B-
2, but not anti-UNC5B-1, causes UNC5B internalization and decrease of surface GFP fluorescence.
(G) Analysis of Src and phospho-Src levels in HUAECs treated with anti-UNC5B-2. Error bars represent SEM. **p < 0.01, ***p < 0.001 (Student’s t test) (see also
Figure S3).
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IgG-like domains of human UNC5B (Figure 3D). One antibody,
anti-UNC5B-1, bound human but not mouse UNC5B, whereas
anti-UNC5B-2 bound both human and mouse receptors with38 Developmental Cell 20, 33–46, January 18, 2011 ª2011 Elsevier Inhigh affinity (Figure 3E). SPR experiments showed that anti-
UNC5B-2 interferes with Netrin-1 binding to immobilized
UNC5B-Fc (Figure S3B). Incubation of UNC5B-GFP PAECs
with anti-UNC5B-2, but not with anti-UNC5B-1, inducedc.
Developmental Cell
Robo4 Interacts with UNC5BUNC5B internalization (Figure 3F). In vivo injection of anti-
UNC5B-2 (20 mg/kg, P0 and P3) into neonatal mice followed
by staining of the retinal vasculature with a polyclonal anti-
UNC5B antibody at P5 also led to almost total disappearance
of UNC5B labeling in the vasculature (Figure S3C). Anti-
UNC5B-2 did not induce Src phosphorylation in HUAECs (Fig-
ure 3G), indicating that anti-UNC5B-2 does not activate
UNC5B signaling, but blocks UNC5B function by inducing
internalization.
Robo4 UNC5B Signaling Counteracts VEGF-Mediated
Src Activation
As Robo4 stimulation of HUAECs recruited phospho-Src to
UNC5B, we hypothesized that this could reduce phospho-Src
association with VEGFR2 and so reduce VEGFR2 activity. We
stimulated HUAECs or primary wild-type mouse EC with VEGF
in the presence of anti-Robo4-1 or anti-UNC5B-2 antibodies to
block the Robo4-UNC5B interaction, or of sRobo4 to activate
UNC5B (Figures 4A and 4B). After VEGFR2 immunoprecipita-
tion, anti-UNC5B-2 and anti-Robo4-1 significantly increased
VEGF-mediated Src and phospho-Src association to VEGFR2
(Figures 4A and 4B). Conversely, stimulation of UNC5B with
sRobo4 decreased VEGF-mediated Src and phospho-Src asso-
ciation to VEGFR2 (Figures 4A and 4B). VEGF-treated Unc5b/
mouse EC did not show any detectable changes in Src associa-
tion with VEGFR2 after sRobo4 or blocking antibody treatment
(Figure 4C), supporting a model whereby Robo4 activation of
UNC5B competes with VEGF-VEGFR for Src activation and
downstream signaling by sequestering Src away from VEGFR2.
Blocking Robo4-UNC5B Interaction Increases
Angiogenesis In Vivo
Because Robo4-UNC5B counteracts VEGF signaling in vitro, we
exploited the mouse corneal pocket assay to test if the Robo4-
UNC5B interaction has an effect on VEGF-mediated angiogenic
sprouting. Intraperitoneal injection with anti-Robo4-1 signifi-
cantly increased corneal neovascularization (Figures 4D and
4E) similar to the increase seen in Robo4/ mice compared to
wild-type littermates (N.R., unpublished data). Treatment with
anti-UNC5B-2 also induced significant corneal hypervasculari-
zation (Figures 4D and 4E). Compared to anti-Robo4-1 treat-
ment, anti-UNCB-2 treatment leads to a different phenotype in
the cornea, i.e., smaller total neovessel area, but denser more
disorganized vessels at the leading front (Figure 4E; Figure S4).
These observations suggest that Robo4 could act independently
of UNC5B during corneal neovascularization. We therefore
treated animals with anti-Robo4-1 and anti-UNC5B-2 simulta-
neously. The hypervascularization of this combination treatment
quantitatively and qualitatively mimics the anti-UNC5B-2 treat-
ment (Figures 4D and 4E), supporting our cell-based data that
Robo4 and UNC5B interact and that Robo4 acts upstream of
UNC5B.
Robo4 Is Dispensable for Developmental Angiogenesis
To investigate if blocking UNC5B-Robo4 interactions has an
effect on developmental angiogenesis we treated neonatal
mice with function-blocking antibodies. Treatment with anti-
UNC5B-2 caused significant hypervascularization of retinal
vessels, mimicking the effect of genetic loss of Unc5b functionDeve(Figure 5). In contrast, anti-Robo4-1 treated or Robo4/ mice
showed normal retinal vascular development (Figure 5).
UNC5B is therefore required in the developing vasculature to
prevent excessive branching, confirming and extending previous
results (Bouvree et al., 2008; Larrivee et al., 2007; Lu et al., 2004).
Robo4 function in the developing vasculature is dispensable;
suggesting that absence of Robo4 may be compensated by
another UNC5B ligand.
Blocking Robo4 UNC5B Interaction Causes Vessel
Hyperpermeability
As Robo4/ mice exhibit increased basal retinal vascular
permeability (Jones et al., 2008), we tested if this was due to
disruption of Robo4-UNC5B interactions. We injected fluores-
cent microspheres into Robo4/ mice and mice treated with
blocking mAbs. Microsphere extravasation was significantly
enhanced in Robo4/ mice and mice treated with anti-Robo4-
1 and anti-UNC5B-2 compared to mice injected with anti-
UNC5B-1 control mAb (Figure 6A). This indicates that blocking
Robo4-UNC5B interaction disrupts retinal vessel barrier integ-
rity. To quantify vessel barrier function, we used a Miles assay,
where Evan’s blue is injected into the tail vein, followed by
intradermal injection of VEGF or saline and quantification of
dye leak into the skin. Robo4/ mice exhibited significant
increase in basal endothelial permeability compared to wild-
type littermates (Figure 6B). The breakdown of endothelial barrier
function seen in Robo4/ mice could be mimicked by intra-
dermal injection of anti-UNC5B-2 and anti-Robo4-1 (Figure 6C).
Increased basal vascular permeability in Robo4/ mice and
mice treated with the blocking antibodies was expected to acti-
vate compensatory physiological responses to maintain blood
pressure. Robo4/ mice and mice treated with anti-UNC5B-2
or anti-Robo-4-1 for four days showed a significant increase in
plasma renin levels and in the number of renin+ glomeruli
compared to wild-type mice or mice treated with anti-UNC5B-1
(Figures S5A and S5B). Activation of the renin-angiotensin
system therefore contributes to physiological adaptation to
vessel barrier breakdown after disruption of the Robo4-UNC5B
interaction.
If Robo4 maintains vessel integrity by activating UNC5B,
soluble Robo4 protein should rescue vessel hyperpermeability
in Robo4/ mice. Indeed, intradermal injection of sRobo4 into
Robo4/ mice restored vessel barrier function (Figure 6B).
SRobo4 also reduced VEGF-induced hyperpermeability in
wild-type mice, but not in mice treated with anti-UNC5B-2
(Figures 6D and 6E), supporting a model whereby Robo4 main-
tains vessel integrity by binding and signaling through UNC5B.
Because blocking of the Robo4-UNC5B interaction increased
Src association with VEGFR2 in vitro (Figures 4A and 4B),
we reasoned that vessel barrier breakdown might reflect exces-
sive VEGF signaling and Src kinase activation. Accordingly,
combined treatment using anti-UNC5B-2 or anti-Robo4-1
together with s-flt-1 or PP2 restored vessel barrier function
(Figures 6F and 6G).
Vascular permeability is known to be regulated in part by Src,
which phosphorylates VE-cadherin and promotes its internaliza-
tion and disassembly of intercellular junctions. To test if Robo4-
UNC5B interactions would influence VE-cadherin phosphoryla-
tion, we treated HUAECs with VEGF in the presence of sRobo4,lopmental Cell 20, 33–46, January 18, 2011 ª2011 Elsevier Inc. 39
Figure 4. Robo4-UNC5B Counteracts VEGF Signaling In Vitro and VEGF-Induced Neovascularization In Vivo
(A) HUAECs, (B) wild-type, and (C) Unc5b/mouse ECs were serum starved and stimulated with VEGF for 5 min. Parallel cultures were pre-treated with sRobo4,
anti-Robo4-1, or anti-UNC5B-2beforeVEGFstimulation. VEGFR2was immunoprecipitated fromcultures andwesternblotswereprobedwith indicatedantibodies.
Pretreatment with sRobo4 decreases Src and phospho-Src association with VEGFR2, while blocking of the Robo4-UNC5B interaction with anti-UNC5B-2 or anti-
Robo4-1 increasesSrc associationwith VEGFR2compared to control in (A) and (B), but not inUnc5b/EC (C). VEGFR2and phospho-VEGFR2 levels are similar in
all treatment conditions. Quantification of four independent experiments is shown. Bars represent SEM. *p < 0.05, **p < 0.01 (Mann-Whitney test).
(D and E) Mouse corneal pocket assay (D) Representative images of entire corneas stained with anti-CD31 illustrating the effects of intracorneal placement of
a 175 ng pellet of VEGF and systemic treatment (i.p. injection) of anti-Robo4-1 (20 mg/kg), anti-UNC5B-2 (25 mg/kg), and combined treatment with both anti-
bodies. (E) Quantification of the neovascularization area from the experiment described in (D). All groups are statistically significantly different from each other,
except for anti-UNC5B-2 and anti-UNC5B-2 + anti-Robo4-1 treatment groups (see also Figure S4).
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Figure 5. Blocking UNC5B, But Not Robo4, Leads
to Retinal Hypervascularization
(A) Confocal images of isolectin-B4 stained retinal whole-
mounts at P5 after IP treatment with the indicated anti-
bodies (25 mg/ml) at P1, P2, P3, and P4. The number of
branch points per retina was quantified using computer-
assisted software (see yellow and blue pixels on the
images after zooming in). Scale bar represents 125 mm.
(B) Quantification of retinal vascularization in P5 CD1-
Unc5b-LacZ-plap mice. Wild-type values were set as 1
(corresponding to a total of 5478 ± 355 branch points
per retina). Note hypervascularization in Unc5b/ retinas
(corresponding to 10639 ± 1258 branch points per retina).
Seven litters comprising viableUnc5b/ pupswithweight
comparable to wild-type littermates were analyzed. (WT,
n = 12; het, n = 14; KO, n = 12).
(C) Quantification of retinal vascularization after anti-
UNC5B treatment. C57/Bl6 litters (n = 4) were injected
and values in noninjected wild-type littermates were set
as 1 in (C) and (E). (noninjected, n = 6; anti-UNC5B-1,
n = 13; anti-UNC5B-2, n = 17). Note that anti-UNC5B-1,
which does not bind to mouse UNC5B has no effect on
retinal vascular development, whereas anti-UNC5B-2
leads to hypervascularization.
(D) Quantification of retinal vascularization in P5 Robo4
mice. Wild-type values were set as 1 (corresponding to
a total of 4834 ± 239 branch points per retina on
a C57/Bl6 background). Four litters were analyzed. (WT,
n = 5; het, n = 8; KO, n = 8).
(E) Quantification of retinal vascularization after anti-
Robo4-1 treatment. Three litters were analyzed. (non-
injected, n = 6; anti-UNC5B-1, n = 13; anti-ROBO4,
n = 10). Note no change in retinal vascularization in
Robo4/ (D) or after anti-Robo4-1 treatment (E).
***p < 0.001, Mann-Whitney test.
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herin phosphorylation, whereas anti-UNC5B-2 and anti-
Robo4-1 significantly increased VEGF-mediated VE-cadherin
phosphorylation (Figure S5C). Therefore, phospho-Src and
VEGF-stimulated phospho-VE-cadherin both respond to activa-
tion or inhibition of the Robo4-UNC5B pathway, supporting
a model where Robo4 activation of UNC5B competes with
VEGF for downstream Src activation, VE-cadherin phosphoryla-
tion, and junctional disassembly (Figure 7).
DISCUSSION
Robo4 Binds UNC5B
The results presented here identify UNC5B as a Robo4 binding
partner. We show that the Robo4 ECD selectively binds to the
UNC5B ECD in a large-scale protein interaction screen. SPR
binding assays confirm specific Robo4-UNC5B binding and
show that theN-terminal 2 Ig-like domains of Robo4 are sufficient
to bind to the thrombospondin-like domains of UNC5B with high
affinity. In cell-based binding assays, Robo4 and UNC5B selec-
tively bind to each other, and the presence of UNC5B in vivo is
required for Robo4-AP binding. Although we cannot exclude
that additional, as yet unidentified Robo4 ligands exist, UNC5B
may be the major Robo4 partner in vivo, because Robo4 binding
was completely abolished in Unc5b deficient embryos, andDevebecause among1900 protein samples, comprising1000 indi-
vidual proteins, only UNC5B-Fc bound Robo4.
Absence of Robo4-Slit-2 Binding
Our data fail to provide any evidence for Slit-2 binding to Robo4,
arguing against Robo4 as a Slit-2 receptor, as reported previ-
ously (Hohenester et al., 2006; Suchting et al., 2005). In further
support of the idea that Robo4 is not a receptor for Slits, a recent
high resolution structure of the two N-terminal Ig like domains of
Robo1 identified keySlit binding residuesand revealed aheparan
sulfate/heparin binding site that strengthens the Slit-Robo1 inter-
action (Fukuhara et al., 2008; Hussain et al., 2006; Morlot et al.,
2007). Although the N-terminal Ig like domains of Robo1 and
Robo4 are 42% identical, none of the residues identified as Slit
or heparin binding are conserved inRobo4, and they are replaced
by residues that appear incompatible with binding Slits or
heparin. Consistent with their structural analysis of Slit-Robo1
binding, Fukuhara et al. (2008) also reported that Robo4 did not
bind to a heparin affinity column. In contrast to these data,
another group has reported that Slit-2 functions via Robo4 to
inhibit VEGF downstream responses, preventing excessive
angiogenesis and permeability (Jones et al., 2008; London
et al., 2010; Marlow et al., 2010; Park et al., 2003). Treatment of
mice with Slit-2 was shown to decrease vascular permeability
and angiogenesis in response to VEGF and inflammatory stimuli,lopmental Cell 20, 33–46, January 18, 2011 ª2011 Elsevier Inc. 41
Figure 6. Robo4-UNC5B Interactions Stabilize Vessels
(A) Confocal images of fluorescent microsphere extravasation (green) from VE-cadherin-stained retinal vessels (red) of mice as indicated. Scale bar represents
10 mm. Quantification of bead extravasation on 10 images/retina from 3 animals/group is shown.
(B–G) A Miles assay was used to measure dermal microvessel permeability. Each panel corresponds to 4–10 mice per group. Bars represent SEM. **p < 0.01
(Mann-Whitney test). (B) Increased basal vessel permeability in Robo4/ mice is rescued by intradermal injection of 2ug sRobo4. (C) Intradermal injection of
20 mg anti-Robo4-1 and UNC5B-2 increases vessel permeability. (D) sRobo4 reduced hyperpermeability induced by VEGF (50 ng) in wild-type mice. (E) sRobo4
does not decrease vessel permeability in mice treated with anti-UNC5B-2. (F and G) Increased vessel permeability induced by antibody treatment is rescued by
injection of sflt-1 (2 mg) (F) or PP2 (10 mM) (G). Bars represent SEM. *p < 0.05, ***p < 0.001 (Mann-Whitney test) (see also Figure S5).
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rendering mice resistant to bacterial infections (Jones et al.,
2008; London et al., 2010). Slit-2 responses were lost in Robo4-42 Developmental Cell 20, 33–46, January 18, 2011 ª2011 Elsevier Indeficient mice, indicating that Slit-2 acted in a Robo4-dependant
manner. However, Slit-2 might bind EC via other receptors,














Figure 7. Working Model for Robo4-UNC5B Interaction
The data suggest that Robo4 inhibits VEGF-driven permeability and angiogen-
esis by binding and signaling through UNC5B, likely by activating UNC5B on
neighboring cells in trans. Blocking Robo4-UNC5B interaction enhances
VEGF-driven permeability and angiogenesis in vivo, indicating that Robo4-
UNC5B signaling counteracts VEGF signaling. Absence of Robo4, e.g., in
the developing vasculature, can be compensated for by alternative UNC5B
interacting proteins, including several possible candidates, i.e., Netrin-1,
Netrin-3, FLRT3, or Netrin-4 and RGM via Neogenin.
Developmental Cell
Robo4 Interacts with UNC5Bcan be coimmunoprecipitated with Robo1 in cultured EC in vitro
(Kaur et al., 2008; Sheldon et al., 2009), suggesting that Robo1-
Robo4 heterodimerization could confer Slit responsiveness,
leading to Robo1 and/or Robo4 signaling and cellular responses
(Huminiecki et al., 2002; Kaur et al., 2008; Tang et al., 2008). Our
data do not exclude such a scenario, however, we did not detect
Robo1-Robo4 interactions by SPR in vitro, nor could we detect
any Robo1 expression in EC in vivo, using in situ hybridization
on mouse embryos (data not shown). Clearly, additional work is
required to understandSlit-2 actions during angiogenesis in vivo.
Robo4 Activates UNC5B Signaling and Inhibits
VEGF-Mediated VEGFR2 Signaling
Previous studies have shown that Robo4 can associate with
intracellular signaling molecules including WASP, cdc42, and
Rac1, indicating potential signaling roles of Robo4 (Kaur et al.,
2008; Sheldon et al., 2009). Our results do not exclude such
a possibility, although we have no evidence for Robo4 signaling.
Stimulation of Robo4-expressing PAECs with UNC5B failed to
elicit Robo4 internalization. Moreover, we consistently observe
low Robo4 cell surface expression in primary cultured EC and
on transfection of Robo4 constructs. Rather than acting as
a receptor, our data support a model where Robo4 functions
as a ligand for the UNC5B receptor in the vasculature (Figure 7).
Robo4 activates UNC5B, Src phosphorylation and Src associa-
tion with UNC5B, which decreases Src kinase association with
VEGFR2 and VE-cadherin phosphorylation after VEGF stimula-
tion. Conversely, blocking Robo4-UNC5B interaction and
UNC5B signaling increases Src kinase association with VEGFR2
and VE-cadherin phosphorylation, suggesting that Robo4-
UNC5B competes with VEGF-VEGFR2 for downstream
signaling cascades in EC.
Robo4-UNC5B Interactions Inhibit Angiogenesis
in a Corneal Pocket Assay, but Not during Development
Using corneal pocket assays with VEGF-containing implants, we
show that treatment with anti-Robo4 and anti-UNC5B anti-Devebodies causes hypervascularization in response to VEGF, similar
to the phenotype seen in Robo4/mice. Thus, both Robo4 and
UNC5B appear to negatively regulate angiogenesis in this in vivo
model. However, vessel morphologies are different between
groups: anti-Robo4 treated corneas exhibit less-branched
mostly vertical vessels, whereas anti-UNC5B treatment leads
to more highly branched vessels with horizontal sprouting,
resulting in generally denser vessels at the leading front (Fig-
ure S4). In addition to these morphological differences, the neo-
vascularization area induced by anti-Robo4 treatment is also
larger than the one induced by anti-UNC5B treatment. The
reason for these differences can be explained by the different
modes of action of the two antibodies: anti-UNC5B-2 internal-
izes the receptor and therefore interferes with all UNC5B-depen-
dent pathways (see below), whereas anti-Robo4-1 specifically
blocks the interaction with UNC5B. Interestingly, treatment
with both antibodies at the same time mimics the anti-UNC5B
phenotype, indicating that Robo4 acts upstream of UNC5B.
Together with our PAE cell-culture and in vivo permeability
data, the corneal pocket experiments therefore support a model
where Robo4 activates UNC5B thereby inhibiting VEGFR-
induced angiogenic signaling (Figure 7).
Hypervascularization after blocking of UNC5B is also seen in
postnatal retinal vessels, confirming and extending our previous
reports that UNC5B functions as a negative regulator of develop-
mental angiogenesis (Bouvree et al., 2008; Larrivee et al., 2007;
Lu et al., 2004). As deletion of Robo4 leaves retinal vessels
unaffected, we suggest that additional UNC5B ligands may
compensate for the absence of Robo4 during developmental
angiogenesis. We show that Netrin-1 can mimic Robo4 effects
on repulsion of UNC5B expressing cells and Src activation via
UNC5B. Deletion of Ntn-1 also leaves developmental angiogen-
esis unaffected (G. Strasser and K. Bouvre´e, unpublished
results). In addition to Robo4 and Netrin-1, UNC5B binds to
Netrin-3 and FLRT3, a transmembrane molecule implicated in
early mesodermal cell adhesion (Karaulanov et al., 2009; Wang
et al., 1999). UNC5B has also been shown to interact with
Neogenin and to transduce signals initiated by Netrin-4 and
repulsive guidance molecule (RGM) (Hata et al., 2009; Lejmi
et al., 2008). Any of these interactions, alone or in combination,
may therefore compensate for the absence of Robo4 during
developmental angiogenesis. Which combination of UNC5B
ligands mediates developmental angiogenesis remains to be
determined.
Robo4-UNC5B Interactions Stabilize Vessels
Blocking the Robo4-UNC5B interaction leads to vessel barrier
breakdown, indicating that Robo4-UNC5B interactions are
required to maintain vessel integrity and prevent vessel leak
in vivo. Vessel barrier breakdown after Robo4-UNC5B block
can be rescued by a VEGF-trap and the Src inhibitor PP2, sup-
porting the model that UNC5B maintains vessel integrity at least
in part by counteracting VEGF-mediated Src kinase activation.
Treatment of Robo4/mice with Robo4 protein rescued vessel
barrier function, and soluble Robo4 blocked VEGF-induced
permeability in wild-type mice, but not in mice treated with
anti-UNC5B-2, indicating that Robo4 mediates vascular stability
by binding and signaling through UNC5B. Therefore, interaction
between these two receptors in the vasculature is required tolopmental Cell 20, 33–46, January 18, 2011 ª2011 Elsevier Inc. 43
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processes. Treatment with soluble Robo4 may help restore
vascular integrity in diseases characterized by excessive angio-
genesis and vascular leak.
EXPERIMENTAL PROCEDURES
Additional methods can be found in the Supplemental Experimental
Procedures.
Protein Interaction Screens
An ‘‘in-house’’ library (Clark et al., 2003) of over 1900 purified protein
constructs containing Fc or histidine tags was screened for binding to
Robo4-Fc with the Octet system (ForteBio) that uses biolayer interferometry
to detect binding. Library proteins were stored frozen and diluted into HBS-
P buffer (10 mM HEPES [pH 7.4], 0.15 M NaCl and 0.005% [v/v] surfactant
P20) for binding screens. Robo4-Fc was loaded to saturation onto anti-human
Fc biosensors, then washed in HBS-P buffer for 30 s and placed for 3 min in
wells containing library proteins (5 mg/ml) and washed for 30 s. Biosensors
were reloaded for 1 min after two interactions. Binding is presented as
responses >0.2 nM and an unrelated protein was used in parallel screens to
identify unspecific protein binding.
Surface Plasmon Resonance
Binding experiments were carried out by surface plasmon resonance surface
plasmon resonance (SPR) measurements on a Biacore 3000 (GE Healthcare)
or ProteOn XPR36 (Bio-Rad Laboratories) instrument at 25C. Slit2-His and
UNC5B-Fc were immobilized at high surface densities (5000 RU) on an acti-
vated Biacore CM5 sensor chip using standard amine coupling procedures as
described by themanufacturer. Analytes were injected at a flow rate of 5 ml/min
and typically at a concentration of 5 mg/ml in HBS-P for 120 s and allowed to
dissociate for 240 s. Blank surfaces were used for background corrections.
Injections of 10 mM glycine, pH 3.0 at 100 ml/min for 1 min were used to regen-
erate surfaces between two experiments. For affinity measurements, UNC5B
antibodies or UNC5B-Fc were immobilized at low surface densities (500–1000
RU) on an activated ProteOn GLC sensor chip. For kinetic experiments, two-
fold serial dilutions of analytes (60 to 1.875 nM for UNC5B-Ig2-His, 200 to
3.125 nM for Robo4-Ig2-His) were injected in phosphate-buffered saline
(PBS), 0.005% v/v Tween-20 (pH 7.4) at a flow rate of 80 ml/min and sensor-
grams for association and dissociation phases were recorded. Analytes
were injected for 300 s and allowed to dissociate for 600 s. Association rates
(kon) and dissociation rates (koff) were calculated using a one-to-one
Langmuir binding model by simultaneous fitting the association and dissocia-
tion sensorgrams (ProteOn Manager, version 2.0, Bio-Rad). The equilibrium
dissociation constant (KD) was calculated as the ratio koff/kon. For binding
competition experiments hUNC5B-Fc and UNC5B-His proteins were immobi-
lized at high surface densities (3000–4000 RU) on an activated ProteOn GLC
sensor chip. Analytes and 1:1 molar mixtures of analytes were injected in
PBS, 0.005% v/v Tween-20 (pH 7.4) at a flow rate of 100 ml/min and sensor-
grams for association and dissociation phases were recorded as described
above. Data were processed with the ProteOn Manger software (version 2.0,
Bio-Rad).
Alkaline Phosphatase and Immunofluorescence Staining
Procedures used for immunolabeling and production of AP-fusion proteins
were described (Xu et al., 2010). A full description can be found in the Supple-
mental Experimental Procedures.
Cell Culture, Fluorescence-Activated Cell Sorting Analysis
A full description of cell culture methods can be found in Supplemental Exper-
imental Procedures. For fluorescence-activated cell sorting (FACS) analysis,
PAECs were plated onto 6-well plates in complete Dulbecco’s modified
Eagle’s medium (DMEM). The next day, cells were treated with Netrin-1
(recombinant mouse, 500 ng/ml) or Robo4-Ig2-His (sRobo4) UNC5B-Fc
and/or blocking antibodies (100 mg/ml). Cells were detached using Accutase,
washed and their fluorescence was analyzed with FACSCalibur cytometer (BD
Bioscience). The results represent the percentage of the geometric mean44 Developmental Cell 20, 33–46, January 18, 2011 ª2011 Elsevier Incompared to the untreated control of three independent experiments for
each condition.
Immunoblotting and Immunoprecipitation
HUAEC (23 105) were seeded in 60 mm dishes, cultured for 24 hr in ECGM-2
at 37C and 5% CO2. Cells were starved for 12 hr in endothelial basal medium
2 (EBM-2; Promocell) supplemented with 2% FBS, followed by serum-free
EBM-2 for 4 hr and treated with Netrin-1 (recombinant mouse, R&D Systems,
500 ng/ml) or sRobo4 (100 mg/ml). Cells were lysed in RIPA buffer (20 mM Tris
pH 7.5, 60 mM NaCl, 1% Triton X-100, 0.5% deoxycholic acid, 0.1% sodium
dodecyl sulfate, 10% glycerol, 25 mM b-glycerol phosphate, 50 mM sodium
fluoride, 2 mM sodium pyrophosphate, 1 mM sodium orthovanadate, and
13 protease inhibitor cocktail, Calbiochem), proteins were separated on
sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred
to nitrocellulose membrane (Bio-Rad). Membranes were blocked in TBS,
0.1% Tween 20, 5% bovine serum albumin (BSA) followed by incubation at
4C overnight with primary antibodies diluted in blocking buffer: anti-Src,
anti-phospho-Src (Y418), anti-Erk, anti-phospho-Erk, anti-VEGFR2, p-1175
anti-VEGFR2, anti-VE-Cadherin (all 1:1000, Cell Signaling), anti-UNC5B (0.2
ug/ml, R&D Systems), and anti-phospho-Tyrosine clone 4G10 (1:1000;
Upstate). Membranes were washed and incubated with peroxidase-conju-
gated secondary antibodies (1:2000; Pierce) in blocking buffer for 2 hr at
room temperature (RT), and proteins were visualized with enhanced chemolu-
minescence western blotting detection reagents (Pierce). Membranes were
exposed using the Fujifilm LAS-3000 imaging system. PAEC (2 3 106)
UNC5B-FL-GFP were seeded in 100 mm diameter dishes and cultured for
24 hr in complete DMEM. Cells were starved overnight in serum-free DMEM
and treated with the indicated molecules. Protein extracts were prepared by
lysing the cells in NP40-sodium desoxycholate buffer (20 mM Tris pH 7.5,
150 mM NaCl, 0.1% sodium desoxycholate, 0.5% NP40, 10% glycerol,
1 mM b-glycerophosphate, 1 mM NaF, 2.5 mM Na pyrophosphate, 1 mM
Na3VO4, and 13 protease inhibitor cocktail). Five hundred micrograms of total
proteinswere immunoprecipitated using anti-Src (1:100; Cell Signaling) or anti-
VE-Cadherin antibodies (1:50; Cell Signaling) on G-Sepharose beads (GE
Healthcare). Protein separation and immunoblotting were described above.
Generation of Phage Antibodies against UNC5B
Human phage antibody libraries with synthetic diversities in the selected
complementary determining regions (H1, H2, H3, L3) were used for panning.
The Fab fragments were displayed bivalently on the surface of M13 bacterio-
phage particles (Lee et al., 2004). MaxiSorp 96-well immunoplates (Nunc) were
coated overnight at 4C with human UNC5B-Fc or human UNC5B-His protein
(10 mg/ml) and blocked for 1 hr with 2% milk in PBS. The antibody phage
libraries were added and incubated overnight at RT. Plates were washed
with PBST, bound phage eluted with 50 mM HCL and 500 mM NaCl for
30 min, and neutralized with equal volume of 1M Tris base. Recovered phages
were amplified in Escherichia coli XL-1 blue cells. During subsequent selection
rounds, the incubation time of the phage antibodies was decreased to 2 hr and
the stringency of plate washing was gradually increased (Liang et al., 2007).
Phage ELISA and DNA sequencing identified unique and specific phage
antibodies binding to UNC5B ECD. Interesting clones were reformatted to
full length IgGs by cloning VL and VH regions of individual clones into LPG3
and LPG4 vectors, respectively, for transient expression in mammalian cells.
Mouse Corneal Micropocket Assay
The mouse corneal angiogenesis pocket assay was adapted from Cao et al.
(2004). Briefly, hydroxyl methylcellulose and aluminum sucralfate micropellets
(0.2mm3 0.2mm) containing VEGF-A (175 ng, R&D) were coated with Hydron
polymer. CD-1 mice (Charles-River, 12 weeks old) were anesthetized and the
Hydron pellet was implanted into the base of a surgically created corneal
pocket, positioned 1.0–1.4 mm from the corneal limbus. After implantation,
veterinary ophthalmic ointment was applied to the eye. To evaluate the effect
of anti-Robo4-1 and anti-UNC5B-2 on VEGF induced angiogenesis in the
cornea, animals were injected intraperitoneally (i.p.) on day 0, 2, and 4 with
antibodies at 20 mg/kg (anti-VEGF at 5 mg/kg) or with vehicle. After 7 days,
animals were sacrificed and the corneas harvested. Vessels were imaged
using CD31 (hamster anti-mouse CD31, AbD Serotec) and anti-SMA (Cy-3
anti-SMA, Sigma) antibodies.c.
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For microsphere extravasation, 100 ul of green fluorescent microsphere solu-
tion (0.1 um, Duke Scientific) was injected into the tail vein of 6-week-old C57/
bl6 wild-type and Robo4/ or mice injected i.p. with anti-UNC5B-1, anti-
UNC5B-2 or anti-Robo4-1 (20 mg/kg, daily for 4 days before microsphere
injection). Beads were left to circulate for 1 hr, mice were anesthetized
(Ketamin/Rompun) and perfused intracardially with 20 ml of 1% PAF in PBS.
Retinas (six per condition) were dissected and stained. For Miles assay, the
bellies of 6-week-old C57/BL6J Robo4+/+ or Robo4/ female littermates
was shaved and the next day mice were injected intravenously with 100 ml
1% Evan’s blue solution. Thirty minutes after injection, 20 ml of PBS containing
BSA, VEGFA (R&D, 2.5 mg/ml), sRobo4 (100 mg/ml), Flt1-Fc (R&D, 100 mg/ml),
or PP2 (10 mM) with or without blocking antibodies (1 mg/ml) were injected
intradermally into two of four treatment zones. Fifteen minutes (VEGF treat-
ments) or 1 hr later (antibody treatments), the animals were sacrificed, and
skin punch biopsies were incubated in formamide solution at 56C for 24 hr
to extract the dye. The absorbance of the solution was measured with a spec-
trophotometer at 620 nm–405 nm. Between 4–10 mice per group were
analyzed for each panel in Figures 6B–6G. Data are expressed as fold increase
compared to control. Error bars represent standard error of the mean;
Mann-Whitney U-test, * p < 0.05, ***p < 0.001.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at doi:10.1016/j.
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